These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3075554)

  • 1. Semisynthetic human insulin: pharmacokinetics and biological potency in healthy subjects in comparison with highly purified porcine insulin.
    Schulz B; Stöwhas H; Becker R; Steinicke A; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):307-13. PubMed ID: 3075554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and biological activity of the new intermediate-acting insulin L-SNC).
    Schulz B; Menzel R; Ratzmann KP; Heinke P
    Exp Clin Endocrinol; 1987 Dec; 90(3):278-84. PubMed ID: 3330036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mixing regular- and intermediate-acting insulins on their absorption and biological activity.
    Schulz B; Menzel R; Besch W
    Exp Clin Endocrinol; 1988 Mar; 91(1):27-34. PubMed ID: 3286272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical pharmacology of human insulin (Novo) and porcine insulin in normal subjects.
    Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Matsuda A
    Diabetes Care; 1983; 6 Suppl 1():17-22. PubMed ID: 6343032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects.
    Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG; Vølund A; Alberti KG; Home PD
    Diabete Metab; 1982 Jun; 8(2):155-8. PubMed ID: 7049781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action profile of biosynthetic human proinsulin trials with the BIOSTATOR in metabolically normal subjects.
    Bottermann P; Wahl K; Ermler R; Gray IP; Hales CN
    Horm Metab Res Suppl; 1988; 18():6-11. PubMed ID: 3056813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effect of semisynthetic human insulin and porcine insulin on glucose kinetics, plasma free fatty acid and amino acid levels in man.
    Müller R; Berger W; Wick H; Keller U
    Horm Metab Res; 1984 Jun; 16(6):271-4. PubMed ID: 6389293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique.
    Becker RH; Frick AD; Burger F; Scholtz H; Potgieter JH
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):292-7. PubMed ID: 15926116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin to normal man.
    Owens DR; Jones MK; Birtwell AJ; Burge CT; Jones IR; Heyburn PJ; Hayes TM; Heding LG
    Horm Metab Res; 1984 Dec; 16 Suppl 1():195-9. PubMed ID: 6152435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the pharmacokinetics of human protamine sodium insulin with human isophane insulin following subcutaneous injection in normal subjects.
    Burke B; Andrews WJ; Hadden DR
    Diabetes Res; 1987 Apr; 4(4):163-7. PubMed ID: 3304782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of potency of porcine insulin and semisynthetic human insulin at 3 dose levels using the euglycaemic clamp.
    Chisholm DJ; Kraegen EW; Hewett MJ; Lazarus L
    Horm Metab Res; 1983 Sep; 15(9):415-8. PubMed ID: 6357983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the activity and pharmacokinetics of porcine insulin and human insulin (Novo) as assessed by the glucose clamp technique in normal and diabetic man.
    Home PD; Shepherd GA; Noy G; Massi-Benedetti M; Hanning I; Burrin JM; Alberti KG
    Diabetes Care; 1983; 6 Suppl 1():23-8. PubMed ID: 6343033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin.
    Heinemann L; Chantelau EA; Starke AA
    Diabete Metab; 1992; 18(1):21-4. PubMed ID: 1563532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactivity and pharmacokinetics of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection.
    Schatz H; Ammermann S; Laube H; Federlin K
    Horm Metab Res; 1988 Jul; 20(7):445-9. PubMed ID: 3049293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different potencies of biosynthetic human and purified porcine insulin.
    Schlüter KJ; Enzmann F; Kerp L
    Horm Metab Res; 1983 Jun; 15(6):271-4. PubMed ID: 6347857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments.
    Nauck MA; Stöckmann F; Thiery J; Ebert R; Creutzfeldt W
    Horm Metab Res Suppl; 1988; 18():60-7. PubMed ID: 3056814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semisynthetic human insulin: biological and pharmacokinetic effects in normal subjects.
    Brogard JM; Paris-Bockel D; Blickle JF; Cohen B; Pinget M; Stahl A
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):238-43. PubMed ID: 3298081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of five pre-mixed combinations of 'short-' and 'intermediate-acting' (NPH) insulins in healthy subjects following subcutaneous administration.
    Owens DR; Jones AL; Dolben J; Dean JD; Petocz P; Coates PA; Luzio SD
    Diabetes Res; 1993; 22(2):77-86. PubMed ID: 8205740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.